Gurion, R., Gafter-Gvili, A., Vidal, L., Leader, A., Ram, R., Shacham-Abulafia, A., . . . Raanani, P. (2013). Has the time for first-line treatment with second generation tyrosine kinase inhibitors in patients with chronic myelogenous leukemia already come? Systematic review and meta-analysis. Ferrata Storti Foundation.
Citação norma ChicagoGurion, Ronit, et al. Has the Time for First-line Treatment With Second Generation Tyrosine Kinase Inhibitors in Patients With Chronic Myelogenous Leukemia Already Come? Systematic Review and Meta-analysis. Ferrata Storti Foundation, 2013.
Citação norma MLAGurion, Ronit, et al. Has the Time for First-line Treatment With Second Generation Tyrosine Kinase Inhibitors in Patients With Chronic Myelogenous Leukemia Already Come? Systematic Review and Meta-analysis. Ferrata Storti Foundation, 2013.